Literature DB >> 26583911

Tracking and Therapeutic Value of Human Adipose Tissue-derived Mesenchymal Stem Cell Transplantation in Reducing Venous Neointimal Hyperplasia Associated with Arteriovenous Fistula.

Binxia Yang1, Akshaar Brahmbhatt1, Evelyn Nieves Torres1, Brian Thielen1, Deborah L McCall1, Sean Engel1, Aditya Bansal1, Mukesh K Pandey1, Allan B Dietz1, Edward B Leof1, Timothy R DeGrado1, Debabrata Mukhopadhyay1, Sanjay Misra1.   

Abstract

PURPOSE: To determine if adventitial transplantation of human adipose tissue-derived mesenchymal stem cells (MSCs) to the outflow vein of B6.Cg-Foxn1(nu)/J mice with arteriovenous fistula (AVF) at the time of creation would reduce monocyte chemoattractant protein-1 (Mcp-1) gene expression and venous neointimal hyperplasia. The second aim was to track transplanted zirconium 89 ((89)Zr)-labeled MSCs serially with positron emission tomography (PET) for 21 days.
MATERIALS AND METHODS: All animal experiments were performed according to protocols approved by the institutional animal care and use committee. Fifty B6.Cg-Foxn1(nu)/J mice were used to accomplish the study aims. Green fluorescent protein was used to stably label 2.5 × 10(5) MSCs, which were injected into the adventitia of the outflow vein at the time of AVF creation in the MSC group. Eleven mice died after AVF placement. Animals were sacrificed on day 7 after AVF placement for real-time polymerase chain reaction (n = 6 for MSC and control groups) and histomorphometric (n = 6 for MSC and control groups) analyses and on day 21 for histomorphometric analysis only (n = 6 for MSC and control groups). In a separate group of experiments (n = 3), animals with transplanted (89)Zr-labeled MSCs were serially imaged with PET for 3 weeks. Multiple comparisons were performed with two-way analysis of variance, followed by the Student t test with post hoc Bonferroni correction.
RESULTS: In vessels with transplanted MSCs compared with control vessels, there was a significant decrease in Mcp-1 gene expression (day 7: mean reduction, 62%; P = .029), with a significant increase in the mean lumen vessel area (day 7: mean increase, 176% [P = .013]; day 21: mean increase, 415% [P = .011]). Moreover, this was accompanied by a significant decrease in Ki-67 index (proliferation on day 7: mean reduction, 81% [P = .0003]; proliferation on day 21: mean reduction, 60%, [P = .016]). Prolonged retention of MSCs at the adventitia was evidenced by serial PET images of (89)Zr-labeled cells.
CONCLUSION: Adventitial transplantation of MSCs decreases Mcp-1 gene expression, accompanied by a reduction in venous neointimal hyperplasia. (©) RSNA, 2015 Online supplemental material is available for this article.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26583911      PMCID: PMC4836988          DOI: 10.1148/radiol.2015150947

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  51 in total

Review 1.  Clinical trials with adult stem/progenitor cells for tissue repair: let's not overlook some essential precautions.

Authors:  Darwin J Prockop; Scott D Olson
Journal:  Blood       Date:  2006-12-14       Impact factor: 22.113

2.  Platelet lysate consisting of a natural repair proteome supports human mesenchymal stem cell proliferation and chromosomal stability.

Authors:  Ruben Crespo-Diaz; Atta Behfar; Greg W Butler; Douglas J Padley; Michael G Sarr; Jozef Bartunek; Allan B Dietz; Andre Terzic
Journal:  Cell Transplant       Date:  2010-11-19       Impact factor: 4.064

3.  Mesenchymal stem cells attenuate cardiac fibroblast proliferation and collagen synthesis through paracrine actions.

Authors:  Shunsuke Ohnishi; Hideaki Sumiyoshi; Soichiro Kitamura; Noritoshi Nagaya
Journal:  FEBS Lett       Date:  2007-07-23       Impact factor: 4.124

4.  Transarterial wall oxygen gradients at a prosthetic vascular graft to artery anastomosis in the rabbit.

Authors:  S M Santilli; S E Wernsing; E S Lee
Journal:  J Vasc Surg       Date:  2000-06       Impact factor: 4.268

5.  The role of short-term oxygen administration in the prevention of intimal hyperplasia.

Authors:  Charu Lata; Derrick Green; Jing Wan; Sabita Roy; Steven M Santilli
Journal:  J Vasc Surg       Date:  2013-02-01       Impact factor: 4.268

Review 6.  The role of hypoxia in bone marrow-derived mesenchymal stem cells: considerations for regenerative medicine approaches.

Authors:  Ruud Das; Holger Jahr; Gerjo J V M van Osch; Eric Farrell
Journal:  Tissue Eng Part B Rev       Date:  2010-04       Impact factor: 6.389

7.  Cell proliferation in human arteriovenous fistulas used for hemodialysis.

Authors:  M Rekhter; S Nicholls; M Ferguson; D Gordon
Journal:  Arterioscler Thromb       Date:  1993-04

8.  Microinflammation is involved in the dysfunction of arteriovenous fistula in patients with maintenance hemodialysis.

Authors:  Bi-cheng Liu; Li Li; Min Gao; Yan-li Wang; Ji-rong Yu
Journal:  Chin Med J (Engl)       Date:  2008-11-05       Impact factor: 2.628

9.  Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis.

Authors:  M T Abdel Aziz; H M Atta; S Mahfouz; H H Fouad; N K Roshdy; H H Ahmed; L A Rashed; D Sabry; A A Hassouna; N M Hasan
Journal:  Clin Biochem       Date:  2007-05-03       Impact factor: 3.281

10.  Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects.

Authors:  Luis A Ortiz; Frederica Gambelli; Christine McBride; Dina Gaupp; Melody Baddoo; Naftali Kaminski; Donald G Phinney
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-18       Impact factor: 12.779

View more
  16 in total

Review 1.  Future research directions to improve fistula maturation and reduce access failure.

Authors:  Haidi Hu; Sandeep Patel; Jesse J Hanisch; Jeans M Santana; Takuya Hashimoto; Hualong Bai; Tambudzai Kudze; Trenton R Foster; Jianming Guo; Bogdan Yatsula; Janice Tsui; Alan Dardik
Journal:  Semin Vasc Surg       Date:  2016-08-26       Impact factor: 1.000

Review 2.  New Insights into Dialysis Vascular Access: Molecular Targets in Arteriovenous Fistula and Arteriovenous Graft Failure and Their Potential to Improve Vascular Access Outcomes.

Authors:  Timmy Lee; Sanjay Misra
Journal:  Clin J Am Soc Nephrol       Date:  2016-07-11       Impact factor: 8.237

3.  Autologous Adipose Tissue-Derived Mesenchymal Stem Cells Introduced by Biliary Stents or Local Immersion in Porcine Bile Duct Anastomoses.

Authors:  Yi Zhang; Ayushman Sharma; Dong Jin Joo; Erek Nelson; Anan AbuRmilah; Bruce P Amiot; Christen J Boyer; Jonathan S Alexander; Nidhi Jalan-Sakrikar; John Martin; Roger Moreira; Shiraj A Chowdhury; Michele Smart; Allan B Dietz; Scott L Nyberg; Julie K Heimbach; Robert C Huebert
Journal:  Liver Transpl       Date:  2020-01       Impact factor: 5.799

4.  Notch signaling in bone marrow-derived FSP-1 cells initiates neointima formation in arteriovenous fistulas.

Authors:  Ming Liang; Qunying Guo; Fengzhang Huang; Guofeng Han; Ke Song; Jinlong Luo; Hunter Cheng; Hongzhen Hu; Eric K Peden; Changyi Chen; William E Mitch; Jie Du; Xiaodong Fu; Luan Truong; Jizhong Cheng
Journal:  Kidney Int       Date:  2019-02-21       Impact factor: 10.612

5.  Therapeutic Effect of Adipose Derived Mesenchymal Stem Cell Transplantation in Reducing Restenosis in a Murine Angioplasty Model.

Authors:  Chuanqi Cai; Sreenivasulu Kilari; Chenglei Zhao; Michael L Simeon; Avanish Misra; Yiqing Li; Andre J van Wijnen; Debabrata Mukhopadhyay; Sanjay Misra
Journal:  J Am Soc Nephrol       Date:  2020-06-25       Impact factor: 10.121

Review 6.  Arteriovenous conduits for hemodialysis: how to better modulate the pathophysiological vascular response to optimize vascular access durability.

Authors:  Yan-Ting Shiu; Joris I Rotmans; Wouter Jan Geelhoed; Daniel B Pike; Timmy Lee
Journal:  Am J Physiol Renal Physiol       Date:  2019-02-20

Review 7.  Novel Clinical Therapies and Technologies in Dialysis Vascular Access.

Authors:  Edwin A Takahashi; Sreenivasulu Kilari; Sanjay Misra
Journal:  Kidney360       Date:  2021-06-10

8.  Rationale and Trial Design of MesEnchymal Stem Cell Trial in Preventing Venous Stenosis of Hemodialysis Vascular Access Arteriovenous Fistula (MEST AVF Trial).

Authors:  Ameet K Piryani; Sreenivasulu Kilari; Edwin Takahashi; Randall R DeMartino; Jay Mandrekar; Allan B Dietz; Sanjay Misra
Journal:  Kidney360       Date:  2021-09-28

9.  The Role of Repeat Administration of Adventitial Delivery of Lentivirus-shRNA-Vegf-A in Arteriovenous Fistula to Prevent Venous Stenosis Formation.

Authors:  Rajiv Janardhanan; Binxia Yang; Sreenivasulu Kilari; Edward B Leof; Debabrata Mukhopadhyay; Sanjay Misra
Journal:  J Vasc Interv Radiol       Date:  2016-03-02       Impact factor: 3.464

10.  Evaluation of Venous Stenosis Angioplasty in a Murine Arteriovenous Fistula Model.

Authors:  Chuanqi Cai; Binxia Yang; Sreenivasulu Kilari; Yiqing Li; Chenglei Zhao; Amit Sharma; Sanjay Misra
Journal:  J Vasc Interv Radiol       Date:  2019-03-20       Impact factor: 3.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.